Harbin Pharmaceutical Group issued an announcement regarding unusual trading. After a self-inspection, the company confirmed that its current production and operation status are normal, and there have been no significant changes in the internal and external operating environment. There are no major matters affecting the abnormal fluctuations in the company's Stocks trading prices, and there is no significant information that should have been disclosed but has not been.
哈药股份：不存在应披露而未披露的重大信息
Harbin Pharmaceutical Group: There is no significant information that should have been disclosed but was not.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney